in Healthcare IT, News
ViraCyte Secures NIH, FDA Grants to Develop, Test T-Cell Immunotherapies
ViraCyte has secured $3.75 million in contracts from the National Institutes of Health and the Food and Drug Administration to continue development work on cellular immunotherapies designed to protect stem cell transplant recipients from severe infections. NIH’s National Heart, Lung and Blood Institute awarded ViraCyte a $3 million contract to advance clinical development of a T-cell immunotherapy […] More